UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program

by Canon Medical Systems Corporation

EchoNext

by Pathway Labs

AI Verdict

Tool A, UltraExtend NX, is an on-premise ultrasound image analysis program designed for cardiologists to perform detailed cardiac motion tracking and measurement for post-processing and procedure planning. Tool B, EchoNext, is an AI tool that analyzes standard ECGs to detect hidden structural heart disease, offering a broader screening capability for various specialties through a clinical decision support platform. While both are FDA-cleared cardiology AI tools, their distinct input data (ultrasound vs. ECG) and primary use cases (detailed analysis vs. screening) make them adjacent rather than direct competitors.

Choose UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program if…

Choose UltraExtend NX CUW-U001S V2.0 if your cardiology department requires advanced, AI-enabled post-processing and offline analysis of ultrasound images. This tool is ideal for optimizing workflow in complex cardiac motion tracking, 2D/3D wall motion analysis, and precise quantification for procedure planning, especially when leveraging Canon's raw data architecture.

View UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program →

Choose EchoNext if…

Choose EchoNext if your practice needs an accessible, non-invasive AI tool to screen for hidden structural heart disease using standard ECGs. This is particularly useful for broad patient populations in various settings, from major hospitals to community practices, to identify risks for conditions like heart failure, valve disease, and pulmonary hypertension.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program	EchoNext
Pricing	Contact for pricing	Starts at $600/month
Deployment	On-premise	Available through the OpenEvidence clinical decision support platform.
BAA Available	Unknown	Yes AI-estimated
FDA Status	Yes AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoNext

EchoNext analyzes standard ECGs, a widely available and inexpensive test, making it highly accessible and easy to integrate into existing workflows without new equipment. UltraExtend NX, while offering a complete offline workflow and robust analysis, requires data from specific Canon ultrasound systems, which could limit its immediate usability for practices without that existing infrastructure.

Clinical Value

EchoNext

EchoNext demonstrates superior clinical value by detecting hidden structural heart disease from routine ECGs with higher accuracy (77%) than cardiologists (64%), even those using AI assistance. This allows for earlier identification of critical conditions like heart failure and valve disease, potentially leading to life-saving interventions. UltraExtend NX provides advanced cardiac motion tracking and measurement for offline analysis of ultrasound images, which is valuable for optimizing workflow and planning complex procedures, but it relies on existing ultrasound data rather than offering a novel screening capability.

Pricing & Value

EchoNext

EchoNext offers transparent tiered pricing starting at $600/month, with discounts and add-ons clearly outlined, providing a predictable cost structure. Its use of standard ECGs also makes it a cost-effective screening tool, potentially reducing the need for more expensive imaging. UltraExtend NX requires contacting the vendor for pricing, which lacks transparency. While it offers workflow optimization, its reliance on specific, potentially high-cost ultrasound equipment from Canon could imply a higher overall investment.

Enterprise Readiness

EchoNext

EchoNext is deployed through the OpenEvidence clinical decision support platform, which is used by over half a million US clinicians, indicating strong enterprise readiness and broad accessibility. It also has a BAA and is HIPAA compliant. UltraExtend NX is an on-premise solution and while it supports integration with PACS, its enterprise readiness is less explicitly detailed regarding broad platform integration or specific compliance agreements beyond expected HIPAA compliance.

Innovation

EchoNext

EchoNext represents a significant innovation as the world's first FDA-approved AI tool to detect hidden structural heart disease from standard ECGs, a test traditionally not used for this purpose. This capability can revolutionize early screening for heart disease. UltraExtend NX offers AI-enabled advanced cardiac motion tracking and measurement, which enhances existing ultrasound analysis, but it is an incremental improvement on an established diagnostic modality.

Support & Docs

Tie

Neither tool's provided information or web search results offer specific details about their support services or documentation beyond general product descriptions. Therefore, it is not possible to definitively pick a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program	EchoNext
Product Name	UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program	EchoNext
Company	Canon Medical Systems Corporation	Pathway Labs
Key Features	AI-enabled advanced cardiac motion tracking and measurement; 2D and 3D Wall Motion Tracking with Full-assist function; Auto EF LV with Full-assist functions for cardiac analysis; Post-processing analysis of ultrasound images; Complete offline workflow for data organization, review, analysis, documentation, and reporting; Leverages Canon's raw data architecture for streamlined workflow; Precise and reproducible cardiac quantification; Robust tools for planning complex procedures (e.g., THV deployment, clipping) based on 3D TEE data	AI-powered ECG analysis; Detection of hidden structural heart disease; Identifies heart failure risk; Screens for valve disease; Detects pulmonary hypertension indicators; Utilizes standard 12-lead ECGs; FDA-cleared technology; Non-invasive diagnostic support
Categories	Cardiology AI	Cardiology AI, Clinical Decision Support & Reference, Lab & Diagnostics
Specialties	Cardiology, Cardiothoracic Surgery	Cardiology, Family Medicine, Hospital Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program and EchoNext.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing cardiology workflows and EHR systems?

UltraExtend NX is designed for a complete offline workflow, allowing for post-processing analysis of ultrasound images, data organization, review, analysis, documentation, and reporting, which can streamline the workflow by freeing up the ultrasound machine. EchoNext integrates through the OpenEvidence clinical decision support platform and analyzes standard ECGs, suggesting it can fit into routine ECG interpretation workflows.

What is the accuracy and sensitivity of each tool in detecting cardiac conditions?

UltraExtend NX's AI-enabled functionalities for 2D and 3D Wall Motion Tracking and Auto EF LV have demonstrated performance as intended with substantial equivalence to predicate devices. EchoNext has shown high accuracy in detecting hidden structural heart disease, achieving an AUROC of 85% in internal tests and 78-80% in external validation, and in one study, it demonstrated higher accuracy (77%) compared to cardiologists (64%) in identifying structural heart problems.

Given their specialized focus, which tool is a better fit for a general cardiology practice versus a more specialized cardiac surgical setting?

UltraExtend NX, with its advanced cardiac motion tracking, 2D and 3D wall motion analysis, and tools for planning complex procedures based on 3D TEE data, appears well-suited for specialized cardiac settings, including cardiothoracic surgery. EchoNext, which analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, is designed for broad access and can be valuable in general cardiology, family medicine, hospital medicine, and internal medicine for early screening.

What is the expected learning curve for physicians and their teams to effectively use each tool?

UltraExtend NX is described as a simple solution for organizing and managing clinical data and optimizing workflow, suggesting a relatively straightforward learning curve for its post-processing analysis features. EchoNext analyzes standard ECGs, which are routine tests, and aims to provide easily interpretable insights, potentially leading to a manageable learning curve for integrating its diagnostic support into existing practices.

What kind of customer support and resources are available to ensure successful implementation and ongoing use?

For UltraExtend NX, Canon Medical Systems Corporation is the provider, and typically large medical device companies offer comprehensive support, though specific details would require direct inquiry. For EchoNext, Pathway Labs is the company, and its availability through the OpenEvidence platform suggests support may be provided through that ecosystem, in addition to Pathway Labs' own resources.

Are there audit-trail features available in either tool to track AI-driven analysis and physician interactions for clinical and administrative purposes?

The provided information does not explicitly detail audit-trail features for either UltraExtend NX or EchoNext. However, given that both are FDA-cleared medical devices, it is generally expected that they would incorporate some level of data logging and traceability for clinical and regulatory compliance, which would require direct inquiry to the vendors for specifics.

How do these tools support multi-site rollout and data aggregation across different clinical locations?

UltraExtend NX's built-in patient browser and comprehensive connectivity options allow for organizing study data efficiently, even when acquired at multiple sites, and it can fetch data directly from ultrasound machines and local NAS or send results to PACS. EchoNext's deployment through the OpenEvidence clinical decision support platform suggests a scalable model for multi-site access and data aggregation, as clinical decision support platforms are often designed for widespread use across various healthcare settings.